USPTO serial 79129639
Serial No. 79129639
Reviewed by CopyMark Law Group
Reg. 4416601Status 404
- Filing date
- Status date
- Registration date
- Oct 15, 2013
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79129639?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nanjing, 210036 Jiangsu, CN
Nanjing, 210036 Jiangsu, CN
Nanjing, 210036 Jiangsu, CN
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 005 | Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; sterilising preparations; dietary and nutritional supplements for medical use; depuratives for the body | SECTION 71 - CANCELLED | — |
| 042 | Technical research in field of medicines and pharmaceuticals; technical project studies, namely, conducting of technical feasibility studies in field of medicines and pharmaceuticals; research and development of new products for others; quality control for others; product quality testing; pharmaceutical product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; bacteriological research; biological research | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genloci Biotechnologies Inc.
- Other trademarks owned by Genloci Biotechnologies Inc.
- Other trademarks owned by Genloci Biotechnologies Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 20, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 7, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 16, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 16, 2022 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Feb 12, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 21, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 21, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 15, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 15, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 30, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 25, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 24, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2013 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 6, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 29, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 29, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| May 28, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 24, 2013 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| May 23, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |